Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Neuro-Oncology|May 16, 2020
Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusionsAnna Luisa Di Stefano, Alberto Picca, Edouard Saragoussi, et al.
The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.
Cell Reports|July 28, 2023
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomasFrancesca De Bacco, Francesca Orzan, Giovanni Crisafulli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type GliomaAnna Luisa Di Stefano, Alessandra Fucci, Veronique Frattini, et al.
Brain Communications|June 30, 2023
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicityAntonio Farina, Cristina Birzu, Mad-Hélénie Elsensohn, et al.
Nature Genetics|August 7, 2013
The integrated landscape of driver genomic alterations in glioblastomaVeronique Frattini, Vladimir Trifonov, Joseph Minhow Chan, et al.
The International Journal of Biological Markers|September 30, 2009
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysisAngelo Paradiso, Anita Mangia, Claudio Orlando, et al.
Cell|November 19, 2016
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive GrowthBaoli Hu, Qianghu Wang, Y Alan Wang, et al.
Nature Medicine|June 1, 2026
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trialBernhard Gentner, Marica Eoli, Francesca Farina, et al.
Haematologica|June 6, 2024
Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environmentsMarine Baron, Karim Labreche, Marianne Veyri, et al.
Pageof 17